foxo4 dri senolytic peptide mechanism

foxo4 dri senolytic peptide mechanism Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells Peptide Inhibitors Targeting FOXO4-p53 Interactions

Name: foxo4 dri senolytic peptide mechanism Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells Peptide Inhibitors Targeting FOXO4-p53 Interactions
Brand: equiscorp.hu
SKU: 25394367007
Price: 21.92 USD
Availability: InStock
Rating: 4.1017 (18 reviews)

Peptide Inhibitors Targeting FOXO4 p53 Interactions and Inducing Senescent Cancer Cell specific Apoptosis Journal of Medicinal Chemistry FOXO4 DRI Peptide Senolytic & Longevity Research PeptWorld The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway

SKU: 25394367007 · From equiscorp.hu

4.1

USD21.92 USD49.92

Pay in 4 interest-free payments of $5.48 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 5 - Aug 10

Description

Important Safety Reminders Medical Supervision Required: AOD-9604 should only be used under qualified medical supervision Baseline and monitoring laboratory testing is recommended Individual contraindications and health status must be evaluated AOD-9604 is not FDA-approved for any indication Contraindications and Precautions: Pregnancy and breastfeeding (no safety data available) Active malignancy (discuss with oncologist) Pediatric use (not studied in children) Significant organ dysfunction (limited safety data) Report Concerns: Any unexpected symptoms or adverse effects should be reported to your healthcare provider promptly

Why Verified Peptides Matter With rising interest in peptides, many people search for BPC-157 online or look into buying online peptidesbut this comes with risks